pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-552 |
Genomic Coordinates | chr1: 34669599 - 34669694 |
Synonyms | MIRN552, hsa-mir-552, MIR552 |
Description | Homo sapiens miR-552 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-552-5p | ||||||||||||||||||||||||
Sequence | 25| GUUUAACCUUUUGCCUGUUGG |45 | ||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | GPATCH8 | ||||||||||||||||||||
Synonyms | GPATC8, KIAA0553 | ||||||||||||||||||||
Description | G-patch domain containing 8 | ||||||||||||||||||||
Transcript | NM_001002909 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on GPATCH8 | |||||||||||||||||||||
3'UTR of GPATCH8 (miRNA target sites are highlighted) |
>GPATCH8|NM_001002909|3'UTR 1 GTTGGGGGATGGGATCCTAGGTAGGGCCAGGGGAGGAGACCCATAAATGTTCCCTTGGGGGTGTTGAGCCATTAATACCA 81 GCAAGTAGAAGCTGGGATGGGCAGTGTCTGACAGCCAAAGAATTGAGTTTTGGCTTGCAGGGGTGGGTTTAGATTTGAAG 161 TTTGCTTTCAGTTTACTATCAGGGATTTCTTTTTCCTGTCCTCCTCTCAATTTGTCCCTCCCTCTTCTGTGTTTCTAAGC 241 TAGGGAACACCAGTAAGTGCTACCCACCCCTCTGCAGCAACATCTCCAAACTGTCAAGTTTAGATAATCCCCTCCTCCCT 321 CTGCTTTTTTCCTCTGCTCTTCCCTTCTGTAAATTTTAAAACATTTTCCTCCCCTCTGGCCAGTGGGTTGTCACCAGAGC 401 ACTTGCTGTGGGCCCATCTGGTCTTGCCTTCTCAGCGCCACAGGGAAGGCCAAGCTGTTCTAGTGGTGGAAGTGCCACCA 481 TTTTGGGGTAGTATCTTTGACCATCTTTGGTGACGTTACGTTATCCCAGGTGAGGTGGAAAGCGTCTCACCTGGAACCTG 561 ATATAACTCAGGCTGCAATTCCATCCAGTTCCCACATCAACGGAGCCACACATTTGGCACTGTTATCTTGGTATCCCTCA 641 TCCCAGAAGAGGCATCTCCATATCCCAGAAAAGAAGATCCTATCATGAATAAAAGCTGTATGGCCCAGAGAGGAGCTCAT 721 GTGTCTAAAGTGAAGGGTATATTTTCTTCTGTTGTGTTGATGTTTCCTTCTTAATTTATAGGATTTTTTTAATGTAAAAA 801 ATTGCACTGAACTCTATAAACGTAAATGCTGCTTTTTGTAGCTCATATAAAAAAGGTTCCATATTTGTAGTATACTGCAA 881 TAATATTTTTTACATCCAGCTCTTTAAGTGATCCTCGTTCTGGTGGCTTTGTGTAAATATGTTTGCCCTAGTTGAATTAA 961 GAAACTCTAAAGGTTATAAAATGAAAACAAAAAATAAAATATTTGTTTTCTGCTAGATGCAAAACTGACTAAGCATGTAT 1041 ATTTTACCAAACTTATGTATTTTTTGAAGTTATGAACTATAAAATGTTAAAACATTTTTTGCTGGGACAAAATGTTAAGT 1121 AATTTGCAGTATGTAGTGCCCCCAGTATTGGGATTTTTGAGCTAATGGGCAGCAGTCAGCTGGGGGCTTCTGAGGGATGC 1201 TCATCTTTAACAGTCTCCCTCATGTACTTTTGCTGTTTTACACAGAGAAACAGGTAGACCCCACAGAGGAGAAGGAGGGG 1281 ATTCAACAGCTTTATTGTCTGGAAGCAGTGAGATTTGGTGATTGTCTGGGGGGATTCCTGGGTTTCCCTGGGTACCTTGT 1361 TCCAGGCAGTCAGTCCATTTGCCTTCCTAGTACTTAGCCCCCTCTGACAATTTTTTTTTTAATGTGCCTTTTGGGTTGGT 1441 AGAAACGGAAGTAGAAGTAGGCTGGAGGATGAGTTGGGACAGTCTTCCTTTTGTTGGGAGGTGAGCACATTTACAGATAT 1521 TTTGCTTCATAGTTTCCATGCCCTCTGCCCAGCTCAGTTTAGACAGTAAACGTTCCTTGTTTCTTTTCTCCCATGACACT 1601 GACAAGAGGAATTACCACCTCAGCCTCTTTTGCCCCTCTTCTTGCCTTTCACCCAGGCTCTCAGCCCTAATTAACACACT 1681 GACCCAAAGGTGCTTGTGTTGCAGGTCCCATCTCCTTTGATGAGGTTAACAATTCCCACTTTGGCATTTTCCTAACTATT 1761 CGTGTGGCTAGAATTGGTTGGTTGGTCACTTGACAAGAAAAACCATACTTACCTGGGCCAAGGCTCTGTTCCTGCCTTCG 1841 CAAATTCTCAAAAGAGTAAAGTTTATGAAAAGAAAGTGGCAGGCAAACACAACTCTTGACTGCCCTCCCACCCTCCTACC 1921 TGTTCAGTACTCATCTGATTCAGAAGCATCACTTCTTGGATAACTAGCACTGGAAAAATGAAATCATCTGTGTAAGTGAA 2001 GGGACTCATTTTTCTTTGCTTTCAGCCCATGTAAATAAATAATACAGTATTAACATTTTCGTGCTGCTTCCCATTAGCTT 2081 GTAGATTGAGCCATACTCTGGCTGCCTCTTTGCCTTCCTAGGGGCATTTTCTTTAACTTCCAGAATAGTGATTTTAAAAG 2161 TAAAAATAAAAATAAACCTTACTTACAAGCATAACAGATTGTATTTAACTTTATCACATATGATAGAGATATATATGCTG 2241 TAAAATGAGGGAAAGGAACTTTCTAATAAACCAATGATTTGTGGAAACTTAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545214. RNA binding protein: AGO3. Condition:Control
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
CLIP-seq Support 1 for dataset GSM545214 | |
---|---|
Method / RBP | PAR-CLIP / AGO3 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000591680.1 | 3UTR | UUAAAACAUUUUUUGCUGGGACA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
118 hsa-miR-552-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT060509 | PPP6R3 | protein phosphatase 6 regulatory subunit 3 | 2 | 2 | ||||||||
MIRT061011 | C1ORF21 | chromosome 1 open reading frame 21 | 2 | 6 | ||||||||
MIRT090823 | MBNL1 | muscleblind like splicing regulator 1 | 2 | 4 | ||||||||
MIRT126569 | MASTL | microtubule associated serine/threonine kinase like | 2 | 2 | ||||||||
MIRT147688 | CBX4 | chromobox 4 | 2 | 4 | ||||||||
MIRT191746 | ELMSAN1 | ELM2 and Myb/SANT domain containing 1 | 2 | 4 | ||||||||
MIRT202397 | GPCPD1 | glycerophosphocholine phosphodiesterase 1 | 2 | 2 | ||||||||
MIRT231334 | XRRA1 | X-ray radiation resistance associated 1 | 2 | 8 | ||||||||
MIRT241355 | SLC16A1 | solute carrier family 16 member 1 | 2 | 2 | ||||||||
MIRT280627 | BCL11B | B-cell CLL/lymphoma 11B | 2 | 2 | ||||||||
MIRT287408 | GPATCH8 | G-patch domain containing 8 | 2 | 2 | ||||||||
MIRT314310 | FCHO2 | FCH domain only 2 | 2 | 2 | ||||||||
MIRT321751 | ANKRD46 | ankyrin repeat domain 46 | 2 | 2 | ||||||||
MIRT329335 | ETF1 | eukaryotic translation termination factor 1 | 2 | 2 | ||||||||
MIRT346611 | PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 2 | 6 | ||||||||
MIRT349189 | ZNF557 | zinc finger protein 557 | 2 | 2 | ||||||||
MIRT357416 | HNRNPA0 | heterogeneous nuclear ribonucleoprotein A0 | 2 | 2 | ||||||||
MIRT359670 | NUS1 | NUS1 dehydrodolichyl diphosphate synthase subunit | 2 | 2 | ||||||||
MIRT442751 | PLAG1 | PLAG1 zinc finger | 2 | 6 | ||||||||
MIRT446639 | SPTY2D1 | SPT2 chromatin protein domain containing 1 | 2 | 2 | ||||||||
MIRT450820 | KCNB1 | potassium voltage-gated channel subfamily B member 1 | 2 | 2 | ||||||||
MIRT452304 | EIF5AL1 | eukaryotic translation initiation factor 5A-like 1 | 2 | 2 | ||||||||
MIRT468814 | RSRC2 | arginine and serine rich coiled-coil 2 | 2 | 6 | ||||||||
MIRT471878 | NUFIP2 | NUFIP2, FMR1 interacting protein 2 | 2 | 6 | ||||||||
MIRT472681 | MYCBP | MYC binding protein | 2 | 4 | ||||||||
MIRT473123 | MLLT10 | MLLT10, histone lysine methyltransferase DOT1L cofactor | 2 | 2 | ||||||||
MIRT477434 | EML4 | echinoderm microtubule associated protein like 4 | 2 | 4 | ||||||||
MIRT501254 | SECISBP2L | SECIS binding protein 2 like | 2 | 2 | ||||||||
MIRT501586 | PLCG1 | phospholipase C gamma 1 | 2 | 2 | ||||||||
MIRT503371 | SCAMP1 | secretory carrier membrane protein 1 | 2 | 2 | ||||||||
MIRT504358 | ARID1B | AT-rich interaction domain 1B | 2 | 6 | ||||||||
MIRT504421 | SHC4 | SHC adaptor protein 4 | 2 | 6 | ||||||||
MIRT505497 | SRSF1 | serine and arginine rich splicing factor 1 | 2 | 4 | ||||||||
MIRT505792 | RSBN1 | round spermatid basic protein 1 | 2 | 8 | ||||||||
MIRT506471 | NAA25 | N(alpha)-acetyltransferase 25, NatB auxiliary subunit | 2 | 4 | ||||||||
MIRT507372 | EPS8 | epidermal growth factor receptor pathway substrate 8 | 2 | 2 | ||||||||
MIRT510850 | RAN | RAN, member RAS oncogene family | 2 | 8 | ||||||||
MIRT510986 | PER1 | period circadian clock 1 | 2 | 4 | ||||||||
MIRT512987 | SEZ6L | seizure related 6 homolog like | 2 | 4 | ||||||||
MIRT514937 | GPR141 | G protein-coupled receptor 141 | 2 | 2 | ||||||||
MIRT522131 | NRBF2 | nuclear receptor binding factor 2 | 2 | 6 | ||||||||
MIRT524300 | CTC1 | CST telomere replication complex component 1 | 2 | 8 | ||||||||
MIRT526363 | LSAMP | limbic system-associated membrane protein | 2 | 2 | ||||||||
MIRT526441 | RBM48 | RNA binding motif protein 48 | 2 | 2 | ||||||||
MIRT526534 | MDM2 | MDM2 proto-oncogene | 2 | 4 | ||||||||
MIRT528065 | HES2 | hes family bHLH transcription factor 2 | 2 | 2 | ||||||||
MIRT531043 | TIPARP | TCDD inducible poly(ADP-ribose) polymerase | 2 | 2 | ||||||||
MIRT532313 | FKBP9 | FK506 binding protein 9 | 2 | 4 | ||||||||
MIRT533196 | WASF3 | WAS protein family member 3 | 2 | 4 | ||||||||
MIRT535701 | NAV1 | neuron navigator 1 | 2 | 5 | ||||||||
MIRT536791 | HNRNPA2B1 | heterogeneous nuclear ribonucleoprotein A2/B1 | 2 | 2 | ||||||||
MIRT537228 | GALNT7 | polypeptide N-acetylgalactosaminyltransferase 7 | 2 | 6 | ||||||||
MIRT538247 | CUX2 | cut like homeobox 2 | 2 | 2 | ||||||||
MIRT538476 | CLOCK | clock circadian regulator | 2 | 2 | ||||||||
MIRT538798 | C2CD5 | C2 calcium dependent domain containing 5 | 2 | 2 | ||||||||
MIRT539031 | ATXN7L1 | ataxin 7 like 1 | 2 | 2 | ||||||||
MIRT542043 | SLC25A46 | solute carrier family 25 member 46 | 2 | 2 | ||||||||
MIRT543093 | TNFRSF11A | TNF receptor superfamily member 11a | 2 | 2 | ||||||||
MIRT543545 | INTS2 | integrator complex subunit 2 | 2 | 2 | ||||||||
MIRT554332 | SH3GLB1 | SH3 domain containing GRB2 like, endophilin B1 | 2 | 4 | ||||||||
MIRT556070 | MRFAP1 | Morf4 family associated protein 1 | 2 | 2 | ||||||||
MIRT558125 | ENPP4 | ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative) | 2 | 2 | ||||||||
MIRT559132 | BTG3 | BTG anti-proliferation factor 3 | 2 | 4 | ||||||||
MIRT559423 | ASF1A | anti-silencing function 1A histone chaperone | 2 | 2 | ||||||||
MIRT560026 | ZNF780A | zinc finger protein 780A | 2 | 2 | ||||||||
MIRT566128 | RACGAP1 | Rac GTPase activating protein 1 | 2 | 2 | ||||||||
MIRT566441 | PHF13 | PHD finger protein 13 | 2 | 2 | ||||||||
MIRT568541 | AKT3 | AKT serine/threonine kinase 3 | 2 | 2 | ||||||||
MIRT568626 | ACVR2A | activin A receptor type 2A | 2 | 2 | ||||||||
MIRT576599 | Nav1 | neuron navigator 1 | 2 | 4 | ||||||||
MIRT609438 | USP27X | ubiquitin specific peptidase 27, X-linked | 2 | 2 | ||||||||
MIRT611441 | NRIP3 | nuclear receptor interacting protein 3 | 2 | 2 | ||||||||
MIRT613007 | GABRB1 | gamma-aminobutyric acid type A receptor beta1 subunit | 2 | 2 | ||||||||
MIRT614149 | CEP97 | centrosomal protein 97 | 2 | 2 | ||||||||
MIRT614580 | LHX1 | LIM homeobox 1 | 2 | 2 | ||||||||
MIRT615631 | ATF6 | activating transcription factor 6 | 2 | 4 | ||||||||
MIRT616115 | NDUFS1 | NADH:ubiquinone oxidoreductase core subunit S1 | 2 | 2 | ||||||||
MIRT620351 | WDR75 | WD repeat domain 75 | 2 | 2 | ||||||||
MIRT621733 | TNPO2 | transportin 2 | 2 | 2 | ||||||||
MIRT623718 | HACE1 | HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 | 2 | 2 | ||||||||
MIRT626107 | MYLIP | myosin regulatory light chain interacting protein | 2 | 2 | ||||||||
MIRT630779 | CRLS1 | cardiolipin synthase 1 | 2 | 2 | ||||||||
MIRT632585 | PLCL1 | phospholipase C like 1 (inactive) | 2 | 2 | ||||||||
MIRT635161 | HOXD12 | homeobox D12 | 2 | 2 | ||||||||
MIRT635878 | SIX3 | SIX homeobox 3 | 2 | 2 | ||||||||
MIRT636941 | LIMS3 | LIM zinc finger domain containing 3 | 2 | 2 | ||||||||
MIRT637007 | LIMS3L | LIM zinc finger domain containing 4 | 2 | 2 | ||||||||
MIRT639202 | LRRC9 | leucine rich repeat containing 9 | 2 | 4 | ||||||||
MIRT639388 | PKHD1 | PKHD1, fibrocystin/polyductin | 2 | 2 | ||||||||
MIRT639543 | SMCR7L | mitochondrial elongation factor 1 | 1 | 1 | ||||||||
MIRT642071 | FUT11 | fucosyltransferase 11 | 2 | 2 | ||||||||
MIRT642567 | GDPGP1 | GDP-D-glucose phosphorylase 1 | 2 | 2 | ||||||||
MIRT643035 | SNX24 | sorting nexin 24 | 2 | 2 | ||||||||
MIRT648372 | SMPD1 | sphingomyelin phosphodiesterase 1 | 2 | 2 | ||||||||
MIRT648529 | KIAA1143 | KIAA1143 | 2 | 2 | ||||||||
MIRT652184 | TRIM44 | tripartite motif containing 44 | 2 | 2 | ||||||||
MIRT652945 | SYNC | syncoilin, intermediate filament protein | 2 | 2 | ||||||||
MIRT657012 | KCNK5 | potassium two pore domain channel subfamily K member 5 | 2 | 2 | ||||||||
MIRT658993 | DIP2C | disco interacting protein 2 homolog C | 2 | 2 | ||||||||
MIRT659629 | CDKN2AIP | CDKN2A interacting protein | 2 | 2 | ||||||||
MIRT659769 | CCBE1 | collagen and calcium binding EGF domains 1 | 2 | 2 | ||||||||
MIRT660527 | ARIH1 | ariadne RBR E3 ubiquitin protein ligase 1 | 2 | 2 | ||||||||
MIRT668526 | ERP44 | endoplasmic reticulum protein 44 | 2 | 2 | ||||||||
MIRT687184 | PRKAR1A | protein kinase cAMP-dependent type I regulatory subunit alpha | 2 | 2 | ||||||||
MIRT696280 | IER3IP1 | immediate early response 3 interacting protein 1 | 2 | 2 | ||||||||
MIRT697673 | WASL | Wiskott-Aldrich syndrome like | 2 | 2 | ||||||||
MIRT697716 | VKORC1L1 | vitamin K epoxide reductase complex subunit 1 like 1 | 2 | 2 | ||||||||
MIRT699719 | SESTD1 | SEC14 and spectrin domain containing 1 | 2 | 2 | ||||||||
MIRT701220 | OGDH | oxoglutarate dehydrogenase | 2 | 2 | ||||||||
MIRT701436 | NFYA | nuclear transcription factor Y subunit alpha | 2 | 2 | ||||||||
MIRT701554 | NANOS1 | nanos C2HC-type zinc finger 1 | 2 | 2 | ||||||||
MIRT707559 | CLVS2 | clavesin 2 | 2 | 2 | ||||||||
MIRT707925 | PPP1R3D | protein phosphatase 1 regulatory subunit 3D | 2 | 2 | ||||||||
MIRT711148 | NAA15 | N(alpha)-acetyltransferase 15, NatA auxiliary subunit | 2 | 2 | ||||||||
MIRT719256 | CD44 | CD44 molecule (Indian blood group) | 2 | 2 | ||||||||
MIRT719810 | TXNDC17 | thioredoxin domain containing 17 | 2 | 2 | ||||||||
MIRT722650 | SIGLEC14 | sialic acid binding Ig like lectin 14 | 2 | 2 | ||||||||
MIRT723901 | PEX11A | peroxisomal biogenesis factor 11 alpha | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|